Interventional Cardiology

Specialties

Redefining What's Possible in Interventional Cardiology

From high-risk PCI and complex coronary disease to structural heart interventions and innovative approaches to chest pain, our physicians are advancing minimally invasive care while helping shape the future of interventional cardiology.

2026 Outcomes

Our interventional cardiology team combines advanced technology, clinical expertise and multidisciplinary collaboration to treat some of the most complex cardiovascular conditions. From high-risk PCI and complex coronary disease to structural heart interventions and innovative approaches to chest pain, our physicians are advancing minimally invasive care while helping shape the future of interventional cardiology.

A destination for complex coronary care

We are a major referral center for high-risk PCI and complex coronary disease, including chronic total occlusions (CTO) and left main coronary artery (LMCA) interventions, serving patients from all over Texas, Oklahoma, Louisiana and further.

Our multidisciplinary expertise, supported by advanced imaging, physiology and plaque-modification technologies, allows us to treat highly complex cases.

LIVE CASES BROADCAST TO A GLOBAL AUDIENCE IN FY 2026

INTERVENTIONAL/CORONARY CLINICAL TRIALS

INTERVENTIONAL CARDIOLOGY PUBLICATIONS

Precision at Every Step

IVUS, OCT and FFR for advanced intravascular and physiologic assessment

CT-guided PCI and advanced imaging to support procedural planning and precision

Plaque modification integrated with imaging and physiology to optimize PCI outcomes

Rampart radiation-reduction technology for improved safety

Cath lab-based conscious sedation and intracardiac echocardiography driving improvements in left atrial appendage closure

Advanced Coronary and Chest Pain Clinic

Our Advanced Coronary and Chest Pain Clinic provides specialized evaluation for ANOCA, INOCA and MINOCA, combining coronary CT, stress PET, stress MRI and invasive coronary function testing for complex etiologies.

Leadership in clinical trials and research

Our Plano location served as a site for the ALL-RISE trial, with Karim Al-Azizi, MD, as principal investigator. The international trial found angiography-derived FFR was noninferior to pressure-wire-based assessment for guiding PCI.